Asset

Total 208, page 9/11

No. Organization Therapeutic Area Product Type Title
24 FDA Technology Transfer Oncology Cell therapy Chimeric Antigen Receptor (CAR)-T cells Targeting IL-13Rα2 Positive Human Solid Cancers
24 The Ohio State University Oncology Small molecule STAT3 Inhibitors and Their Anti-Cancer Usage
23 The Ohio State University Immunology, Oncology Antibody Improving Immunotherapy with mRNA Delivery
23 Dana-Farber Oncology Cell therapy LMP1 Based Approach to Producing Multi-specific CD4+ CTLs for Cancer Immunotherapy
22 Dana-Farber Oncology Nucleotide Antisense Inhibitors of Long Noncoding RNA as Treatment for Multiple Myeloma
22 Stanford University Genetic disorders Gene therapy S06-098: Novel AAV capsids with new transduction and nonimmune properties
21 Stanford University Immunology, Oncology Cell therapy MicroRNA Expression in Dendritic Cells for Immune Regulation
21 Cancer Research Horizons Oncology Peptide ɑvß6-binding Peptides for Tumour Targeting and Imaging
20 Cancer Research Horizons Oncology Antibody Conjugated CLEC 14A antibody
20 Stanford University Oncology Antibody Methods to Treat Malignant Pediatric Brain Tumors Using Anti-CD47 Agents
19 Stanford University Ophthalmology Gene therapy miR-494 inhibitor, for the treatment of retinal disease
19 Cancer Research Horizons Oncology Antibody Arginase-2 Inhibitory Antibody
18 Boston University Oncology Antibody High-performance Multiplex Drug-gated CAR Circuits
18 Stanford University Various diseases Antibody S18-179: Lysosome targeting chimeras
17 NIH Oncology Small molecule Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
17 Boston University Oncology Gene therapy Orthogonal Inducible Cas13 Platform for Programmable RNA Regulation
16 Weill Cornell Medicine Immunology, Oncology, Ophthalmology Small molecule Irreversible S1PR2 Antagonists for the Treatment of Inflammation and Fibrosis
16 NIH Oncology Nanoparticle Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery
15 NIH Oncology, Infectious disease Nucleotide siRNA Delivery Using Hexameric Tetrahedral RNA Nanostructures
15 Weill Cornell Medicine Immunology, Oncology Protein Inflammasome Agonist Proteins for Vaccine and Immunotherapy

TOP